Wastewater treatment plants play an important role in antibiotic resistance development. While it 22 has been shown that wastewater effluents contain resistant bacteria, resistance genes, and 23 antibiotics, there is little knowledge on the link between resistance genotype and phenotype. 24
Introduction 40
In 1945, Alexander Fleming, the discoverer of Penicillin, warned of antibiotic resistance. Today, 41 the WHO echoes this warning, calling antibiotic resistance a global threat to human health. 42
Humans are at the center of the modern rise of resistance. The human gut (1), clinical samples 43 (2, 3), soil (4, 5) , and wastewater (6) all harbor resistant bacteria and resistance genes. At the 44 heart of modern resistance development is a human-centered network of clinics, industry, private 45 homes, farming, and wastewater. However, it is unclear, where antibiotic resistance emerges and 46 in particular, there are contradictory views on the role of wastewater treatment plants (6). On the 47 one hand, the harsh environment of a treatment plant appears unfavourable for resistant bacteria 48 (7), but on the other hand, it forms a very rich genetic reservoir, where highly diverse bacteria 49 mingle (6). Also, it is unclear, whether or not any bacteria with pathogenic potential emerge after 50
treatment. 51
To address these questions, we collected 1178 Escherichia coli isolates from a waste treatment 52 plant's inflow and outflow in the city of Dresden, Germany. We selected 20 antibiotics, which are 53 the most prescribed ones in the area from which the wastewater inflow originates (data provided 54 by the public health insurer AOK). We analyzed the isolates' resistance to these 20 antibiotics 55 and selected 103 isolates for whole genome sequencing. Our analysis reveals that wastewater 56 outflow harbors multi-drug resistant Escherichia coli with pathogenic potential and very flexible 57 genomes harboring resistance genes. Escherichia coli, as well as Shigella genomes (see Table 1 ). This underlines the great diversity of 130 genomes before and after wastewater treatment and leads to the question whether these diverse 131 genomes harbour antibiotic resistance genes? 132
133
Figure 3: The pan-genome at the outflow has the same size as at the inflow, suggesting that 134 highly flexible Escherichia coli emerge from a treatment plant. The wastewater pan-genome is 135 larger than a clinical pan-genome one and of similar size to (see Table 1 (12)), they fall mostly into a few groups, such as beta-lactamases. Here, we seek to confirm and 148 expand the space for candidate resistance genes. Firstly, we measured antibiotic resistance in all 149 1178 isolates to the 20 antibiotics. Fig. 4 
Discussion 185
The cost of resistance. There is a debate on whether the evolution of resistance is a 186 competitive disadvantage. Some evidence indicates that resistant bacteria may be outcompeted 187 by susceptible bacteria (13) and that they may be collaterally sensitive (14) environments. It is, e.g., known that the phylogenetic group B2 is more abundant among 230 commensal Escherichia coli from human faeces (43%) than from farm animals (11%) (23). 231 Therefore, the composition of wastewater Escherichia coli as shown in Fig. 2 resembles  232 commensal Escherichia coli from farm animals more closely. Similarly, Tenaillon find that groups 233 A and B1 make up one third in human faeces (23), whereas we find two thirds. This suggests that 234 animal waste plays an important role for resistance of waste water bacteria. 235
Pan and core genome. We identified known and candidate resistance genes by correlating their 236 presence in the genome against their resistance phenotype across isolates. By virtue of this 237 correlation, the identified genes are not to be found in the core genome, but in the pan genome. . coli genomes (24) . This upper limit shows that the 243 wastewater pan genome of 16582 genes is still not the top. Nonetheless, it is considerably larger 244 than a clinical pan genome. These differences indicate the heterogeneity of genomes. Clinical 245
Escherichia coli genomes are not as diverse as the ones in a wastewater pool, which comprises 246 besides human faeces also animal waste. 247
Random sampling and hypothesis-free analysis. The initial 1178 isolates were sampled 248 randomly over different times of the year, from two different inflows and the outflow. In contrast, 249 the 103 sequenced isolates were chosen in such way that all of the phenotypes encountered 250 were represented (see methods). Within a phenotype group isolates were chosen randomly. This 251 random, but representative choice and the subsequent link from genotype to phenotype is an 252 example of high-throughput hypothesis-free analysis. And although, there was no pre-defined 253 resistance mechanism, which we aimed to hit, many of the well-known resistance genes were 254 ranked high. This supports the hope that high-throughput, hypothesis-free methods such as deep 255 sequencing will help to uncover novel resistance mechanisms and in particular that some of the 256 candidate resistance genes will prove to have a causal link to resistance. 257
258

Conclusion 259
Overall, we have shown for the first time that Escherichia coli isolates from a wastewater outflow 260 have pathogenic potential and large pan-genomes, which harbor known and novel candidate 261 resistance genes. Together with the estimates on absolute Escherichia coli abundance, this 262 means that despite treatment, there is a considerable pathogenic potential at the outflow of a 263 wastewater treatment plant. These results underline the need to include wastewater treatment 264 plants in the combat against antibiotic resistance. contamination, picked colonies were spiked a second time on the same selective media and pure 281 single colonies were grown overnight on LB media at 37°C and stored on glycerol stock at -80° C. 282
Resistance phenotyping. Antibiotic resistance phenotypes were determined by the agar 283 diffusion method using 20 antibiotic discs (OXOID, England) according to EUCAST (or CLSI 284 when EUCAST was not available) (13, 18) . The selected drugs belong to the most commonly 285 prescribed antibiotics for diseases caused by bacteria according to the German health insurance 286 AOK Plus: piperacillin (100µg), nalidixic acid (30µg), chloramphenicol (30µg), imipenem (10µg), 287 cefotaxime (30µg), cephalotin (30µg), kanamycin (30µg), tetracycline (30µg), gentamicin (10µg), 288 amikacin (30µg), ciprofloxacin (5µg), fosfomycin (50µg), doxycycline (30µg), cefepime (30µg), 289 ceftazidime (10µg), levofloxacin (5µg), meropenem (10µg), norfloxacin (10µg), cefuroxime sod. 290 (30µg), tobramycin (10µg) (25). After 24 hours of incubation at 37°C, the resistance diameters 291
were measured. Clustering of antibiotics and of isolates was performed using the R function 292
heatmap.2 from the R library (26) Heatplus and hierarchical clustering of matrices based on 293
Euclidean distances between isolates and between antibiotics. 294 295 Sequencing. To select isolates representative of phenotype, we clustered isolates according to 296 the diameters of inhibition zone against the 20 antibiotics using k-means clustering based on 297
Euclidean distances between isolates (vectors of 20 inhibition zone diameters). The analysis and 298
graphs were produced using R version 3.2.4 (26). As clusters may be highly skewed in number of 299 cluster members, we tested all cluster numbers from 1 to 100 and plotted within class sum of 300 squares against k. At k = 47, the sum of squares tails off and there is a steep local decrease, so 301 that k = 47 was fixed as k-means parameter. We obtained 103 isolates, which were subsequently 302 used for sequencing and further analysis. To further validate the choice, we plotted the average 303 number of resistances against number of isolates and antibiotics vs. number of isolates for the 304 total 1178 and the selected 103 isolates (see Supp Fig. 1 ) and concluded that both distributions 305 are roughly similar. 3000ng DNA were extracted from each of the 103 selected isolates using 306
MasterPure extraction kit (Epicentre) according to the manufacturer's instructions. Sequencing 307 was performed using Illumina Flex GL. 308 309 Assembly. Genomes were assembled with Abyss (version 1.5.2) (27). In order to optimize k for 310 the best assembly, k-mer values had to be empirically selected from the range of 20-48 (see 311 Supp. Fig. 2 ) on a per sample basis to maximize contiguity (3). To determine the k-mer length 312 that achieved highest contiguity, the 28 assemblies per draft genome/isolate were compared 313 based on N50 values. 11 assemblies with an N50 statistic of less than 5 × 10 4 bp were excluded 314 (28). 315 317 Genes. Reference gene clusters were computed from 58 complete Escherichia coli genomes 318 (see Table 2 ) available in June 2015 from NCBI. Genes were identified in wastewater and 319 refererence genomes using Prokka (version 1.11) (29). Genes were clustered at 80% using CD-320 HIT (30) (version 4.6.3, arguments -n 4 -c 0.8 -G 1 -aL 0.8 -aS 0.8 -B 1). Genes with over 90% 321 sequence identity, but only 30% coverage, as well as genes with 80% or greater identity and 322 covered to phage and virus sequences (31) were discarded. A gene cluster is defined to be 323 present in an isolate if there is a Prokka gene in the genome, which is longer than 100 amino 324 acids and has over 80% sequence identity and coverage against the gene cluster representative. 325 326 Pan-and core-genome. To generate the pan-and core-genome size graph we followed the 327 procedure in (3, 16). We had 92 genomes available. We varied i from one to 92. At each subset 328 size i, we randomly selected i genomes and computed the sizes of the union (pan) and 329 intersection (core) of gene clusters. This random selection was carried out 2000 times in each 330
step. 331 332
Gene clusters to rank genes by correlation to phenotype. Prokka genes were identified in all 333 isolate genomes and then clustered with CD-HIT at 60% sequence identity and 50% coverage 334 (arguments -n 4 -c 0.6 -G 1 -aL 0.8 -aS 0.5 -B 1). A 80% identity cutoff was also tried but 335 dismissed, because the 60% threshold yielded 25% less clusters while adequately clustering 336 homologous gene sequences with lower sequence similarity. This threshold value is also 337 supported by the widespread default use of the BLOSUM62 matrix, the basis of which is 338 sequences clustered by 62% sequence identity. 339 340 Tree. The phylogenetic tree of 92 isolates was built following the procedure of (32, 33)using 341
FastTree version 2.1 (34). Sequence reads were aligned to Escherichia coli K12 MG 1665 and 342 single nucleotide variant calling was carried out using GATK (35). Quality control for variant 343 calling was performed; variants supported by more than ten reads or likelihood score greater than 344 200 were always in the range of 84 -99% of variants called per isolate with the exception of 2 345 isolates where only 59% and 60% of the variants were above the threshold for quality and 346 supporting reads. FastTree 2.1 (34) was then used to build the maximum likelihood tree based on 347 the sequences derived from variant calling. draBC, bmaE, gafD, iha cds, mat, papEF, papGII, III, sfa/foc, etsB, etsC, sitD 370 ep, sitD ch, cvaC MPIII, colV MPIX, eitA, eitC, iss, neuC, kpsMTII, ompA, ompT, traT, hlyF, GimB, 371 malX, puvA, yqi, stx1, stx2, escV, bfp, feob, aatA, csgA, fimC, focG, nfaE, papAH, papC, sfaS, 372 tsh, chuA, fyuA, ireA, iroN, irp2, iucD, iutA, sitA, astA, cnf1, sat, vat, hlyA, hlyC, ibeA, tia, and pic. 373 374
Data availability statement 375
Genome assemblies of the analyzed isolates that support the findings of the study will be made 376 available on the NCBI upon paper publication (see Table 3 
